Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Brain Neoplasms 9Carcinoma, Non-Small-Cell Lung 3Recurrence 2Melanoma 2Glioblastoma 2Neuroblastoma 1Lung Neoplasms 1Kidney Neoplasms 1Gliosarcoma 1Glioma 1Cognition Disorders 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Filgrastim 7Carboplatin 5Thiotepa 3Temozolomide 3Peripheral Blood Stem Cell Transplantation 3Ifosfamide 3sargramostim 2motexafin gadolinium 2etoposide phosphate 2Sunitinib 2Radiosurgery 2Paclitaxel 2Melphalan 2Immunohistochemistry 2Granulocyte Colony-Stimulating Factor 2Gene Expression Profiling 2Etoposide 2Busulfan 2Amplified Fragment Length Polymorphism Analysis 2Amifostine 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tanespimycin 1pentetreotide 1pembrolizumab 1oblimersen 1liposomal doxorubicin 1ixabepilone 1guadecitabine 1gallium Ga 68 dotatate 1erythromycin propionate-N-acetylcysteinate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Spermine Synthase × CNS × Clear all
NCT03075072 2024-10-23

Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial

Dana-Farber Cancer Institute

Phase NA Active not recruiting
196 enrolled
BreastCNSDermatologicGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡